Advanced Oncotherapy (AVO) said it had made ‘significant progress’ towards achieving its corporate goals over the last 12 months as it announced results for the year ended 31 December 2019. Development of its next generation proton beam therapy LIGHT system accelerated during the period and it is now taking the necessary steps towards regulatory certification….
Membership Required
You must be a HM Subscriber to view this content.
Already have an account? Sign In
©2025 All rights reserved LaingBuisson 
 said it had made ‘significant progress’ towards achieving its corporate goals over the last 12 months as it announced results for the year ended 31 December 2019.){kind=link}